Friday, June 10, 2016

Lupuzor (LON:IMM) could treat a number of diseases, says creator: ProactiveInvestors Stocktube

Published on 10 Jun 2016
Sylvaine Muller, creator of ImmuPharma PLC’s (LON:IMM) lead drug candidate Lupuzor, tells Proactive Investors the treatment is “unique” in its treatment for auto-immune disease lupus, as it only targets only the autoimmune system, and not the immune system.

But, she adds, “we think that we can open up the indications in which the peptide [molecule] could be effective”.

“We have already started some experiments,” Mulller says, which will target a range of diseases including inflammatory, chronic, those related to autoimmunity and those that aren’t - like asthma.
“We have first indication that are extremely promising also in these indications,” she adds.

No comments: